Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003074705 | SCV003460504 | likely benign | Congenital disorder of glycosylation type Ir | 2024-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004071690 | SCV004855127 | uncertain significance | not specified | 2024-01-04 | criteria provided, single submitter | clinical testing | The c.16T>G (p.C6G) alteration is located in exon 1 (coding exon 1) of the DDOST gene. This alteration results from a T to G substitution at nucleotide position 16, causing the cysteine (C) at amino acid position 6 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |